T. Rowe Price Associates’s Xcerra Corporation XCRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-20,609
Closed -$294K 2647
2018
Q3
$294K Buy
20,609
+100
+0.5% +$1.42K ﹤0.01% 2366
2018
Q2
$287K Buy
20,509
+60
+0.3% +$790 ﹤0.01% 2361
2018
Q1
$238K Buy
20,449
+104
+0.5% +$1.07K ﹤0.01% 2370
2017
Q4
$199K Hold
20,345
﹤0.01% 2426
2017
Q3
$200K Hold
20,345
﹤0.01% 2414
2017
Q2
$199K Hold
20,345
﹤0.01% 2387
2017
Q1
$181K Buy
20,345
+46
+0.2% +$379 ﹤0.01% 2414
2016
Q4
$155K Hold
20,299
﹤0.01% 2423
2016
Q3
$123K Hold
20,299
﹤0.01% 2420
2016
Q2
$117K Hold
20,299
﹤0.01% 2401
2016
Q1
$132K Hold
20,299
﹤0.01% 2372
2015
Q4
$123K Buy
20,299
+100
+0.5% +$654 ﹤0.01% 2390
2015
Q3
$127K Hold
20,199
﹤0.01% 2378
2015
Q2
$153K Hold
20,199
﹤0.01% 2403
2015
Q1
$180K Hold
20,199
﹤0.01% 2378
2014
Q4
$185K Hold
20,199
﹤0.01% 2375
2014
Q3
$198K Hold
20,199
﹤0.01% 2348
2014
Q2
$184K Hold
20,199
﹤0.01% 2372
2014
Q1
$180K Hold
20,199
﹤0.01% 2345
2013
Q4
$161K Hold
20,199
﹤0.01% 2354
2013
Q3
$133K Hold
20,199
﹤0.01% 2348
2013
Q2
$121K Buy
+20,199
New +$117K ﹤0.01% 2309

T. Rowe Price Associates's XCRA Position: Q4 2018 in Review

T. Rowe Price Associates sold out of Xcerra Corporation (XCRA) in Q4 2018, closing a stake of 20,609 shares — an estimated $294K sold.

T. Rowe Price Associates first reported a position in XCRA in Q2 2013 and held it in 22 quarters. The position peaked at $294K in Q3 2018. 0 funds tracked by Wall St. Rank hold XCRA as of Q4 2018.

  • T. Rowe Price Associates reported no remaining Xcerra Corporation position as of Q4 2018 after selling out during the quarter.
  • T. Rowe Price Associates sold 20,609 Xcerra Corporation shares in Q4 2018, an estimated $294K.
  • T. Rowe Price Associates first reported a position in Xcerra Corporation in Q2 2013 and held it in 22 quarters.
  • T. Rowe Price Associates's Xcerra Corporation position peaked at $294K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Xcerra Corporation as of Q4 2018.

Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.